| 22nd week of 2021 patent applcation highlights part 26 |
| Patent application number | Title | Published |
|---|
| 20210163572 | Soluble HLA class II complexes and methods of production and uses thereof | 2021-06-03 |
| 20210163573 | IDENTIFICATION OF IMMUNOGENIC MHC CLASS II PEPTIDES FOR IMMUNE-BASED THERAPY | 2021-06-03 |
| 20210163574 | SYNTHETIC SIGNALING CONSTRUCTS AND ITS USE | 2021-06-03 |
| 20210163575 | FACTOR VIII MUTANT EXPRESSION VECTOR WITH ENHANCED PROTEIN EXPRESSION | 2021-06-03 |
| 20210163576 | Preparation Method for Collagen Hydrogel | 2021-06-03 |
| 20210163577 | Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE | 2021-06-03 |
| 20210163578 | HIGH-AFFINITY MYCOBACTERIUM TUBERCULOSIS CAPSULE-SPECIFIC HUMAN MONOCLONAL ANTIBODY | 2021-06-03 |
| 20210163579 | VASCULAR ENDOTHELIAL GROWTH FACTOR/ANTI-FIBRONECTIN ANTIBODY FUSION PROTEINS | 2021-06-03 |
| 20210163580 | ANTI-RSPO3 ANTIBODIES | 2021-06-03 |
| 20210163581 | CONNEXIN 43 ANTIBODIES AND USE THEREOF | 2021-06-03 |
| 20210163582 | ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF | 2021-06-03 |
| 20210163583 | ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF | 2021-06-03 |
| 20210163584 | Bone-Targeting Antibodies | 2021-06-03 |
| 20210163585 | ANTIBODIES SPECIFIC FOR SULFATION SITES OF WNT PATHWAY PROTEINS | 2021-06-03 |
| 20210163586 | GREMLIN-1 CRYSTAL STRUCTURE AND INHIBITORY ANTIBODY | 2021-06-03 |
| 20210163587 | Anti-IL31 Antibodies for Veterinary Use | 2021-06-03 |
| 20210163588 | INTERFERON BETA ANTIBODIES AND USES THEREOF | 2021-06-03 |
| 20210163589 | Antibodies Directed Against Programmed Death-1(PD-1) | 2021-06-03 |
| 20210163590 | NOVEL ANTI-TIM-3 ANTIBODIES | 2021-06-03 |
| 20210163591 | COMPOSITIONS TARGETING GABRA2 AND METHODS FOR DIAGNOSIS AND TREATMENT OF CANCER | 2021-06-03 |
| 20210163592 | CONTINUOUS MANUFACTURING PROCESS FOR BISPECIFIC ANTIBODY PRODUCTS | 2021-06-03 |
| 20210163593 | TREATMENT OF MONOGENIC DISEASES WITH AN ANTI-CD45RC ANTIBODY | 2021-06-03 |
| 20210163594 | BINDING MOLECULES | 2021-06-03 |
| 20210163595 | METHODS OF TREATING VITILIGO USING PD-1 BINDING ANTIBODIES | 2021-06-03 |
| 20210163596 | IMMUNOMODULATORY IL-2 AGENTS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS | 2021-06-03 |
| 20210163597 | INCREASING RESPONSES TO CHECKPOINT INHIBITORS BY EXTRACORPOREAL APHERESIS | 2021-06-03 |
| 20210163598 | TUMOR IMMUNOTHERAPY TARGET AND APPLICATION THEREOF | 2021-06-03 |
| 20210163599 | PD-L1 BINDING AFFIMERS, AND USES RELATED THERETO | 2021-06-03 |
| 20210163600 | ANTI-PD-L1 ANTIBODIES | 2021-06-03 |
| 20210163601 | ASGR INHIBITORS | 2021-06-03 |
| 20210163602 | PSGL-1 MODULATORS AND USES THEREOF | 2021-06-03 |
| 20210163603 | ANTI-FLT-1 ANTIBODIES IN TREATING DUCHENNE MUSCULAR DYSTROPHY | 2021-06-03 |
| 20210163604 | DRUG CONJUGATES OF cMET MONOCLONAL BINDING AGENTS, AND USES THEREOF | 2021-06-03 |
| 20210163605 | RAMUCIRUMAB FOR THE TREATMENT OF CANCERS IN PEDIATRIC PATIENTS | 2021-06-03 |
| 20210163606 | COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES | 2021-06-03 |
| 20210163607 | METHOD FOR SUPPRESSING REGULATORY T CELL INFILTRATION BY CCR4 INHIBITION AND METHOD FOR TREATING CANINE NEOPLASTIC DISEASE | 2021-06-03 |
| 20210163608 | THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT | 2021-06-03 |
| 20210163609 | METHOD FOR TREATING AUTOIMMUNE DISEASE | 2021-06-03 |
| 20210163610 | REFRACTORY ASTHMA PROPHYLACTIC/THERAPEUTIC AGENT SCREENING METHOD, AND REFRACTORY ASTHMA PROPHYLACTIC/THERAPEUTIC AGENT | 2021-06-03 |
| 20210163611 | HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR | 2021-06-03 |
| 20210163612 | CD123 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY | 2021-06-03 |
| 20210163613 | ANTIBODY THERAPEUTICS THAT BIND CD123 | 2021-06-03 |
| 20210163614 | APJ ANTIBODY, FUSION PROTEIN THEREOF WITH ELABELA, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2021-06-03 |
| 20210163615 | CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA AND METHODS OF USE THEREOF | 2021-06-03 |
| 20210163616 | BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF | 2021-06-03 |
| 20210163617 | THERAPEUTIC COMBINATION OF 4-1 BB AGONISTS WITH ANTI-CD20 ANTIBODIES | 2021-06-03 |
| 20210163618 | CHIMERIC CANINE ANTI-CD20 ANTIBODY | 2021-06-03 |
| 20210163619 | ANTIBODY VARIANTS AND USES THEREOF | 2021-06-03 |
| 20210163620 | TRISPECIFIC BINDING MOLECULES AGAINST CANCERS AND USES THEREOF | 2021-06-03 |
| 20210163621 | CHIMERIC RECEPTORS TO DLL3 AND METHODS OF USE THEREOF | 2021-06-03 |
| 20210163622 | IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF | 2021-06-03 |
| 20210163623 | Modified Antibody, Antibody-Conjugate and Process For The Preparation Thereof | 2021-06-03 |
| 20210163624 | T CELL RECEPTOR-LIKE ANTIBODIES SPECIFIC FOR A WTI PEPTIDE PRESENTED BY HLA-A2 | 2021-06-03 |
| 20210163625 | CONJUGATION METHODS | 2021-06-03 |
| 20210163626 | ANTI-VARIANT FC-REGION ANTIBODIES AND METHOD OF USE | 2021-06-03 |
| 20210163627 | NOVEL HETERODIMERIC PROTEINS | 2021-06-03 |
| 20210163628 | MICE THAT MAKE VL BINDING PROTEINS | 2021-06-03 |
| 20210163629 | CARBOXYMETHYLATED CELLULOSE NANOFIBERS | 2021-06-03 |
| 20210163630 | METHOD FOR PRODUCING FUNCTIONALIZED NANOCRYSTALLINE CELLULOSE AND FUNCTIONALIZED NANOCRYSTALLINE CELLULOSE THEREBY PRODUCED | 2021-06-03 |
| 20210163631 | CHARGE-BEARING CYCLODEXTRIN POLYMERIC MATERIALS AND METHODS OF MAKING AND USING SAME | 2021-06-03 |
| 20210163632 | RUBBER COMPOSITION | 2021-06-03 |
| 20210163633 | ACTIVATOR-NUCLEATOR FORMULATIONS | 2021-06-03 |
| 20210163634 | CURABLE COMPOSITION, CURED FILM, INFRARED TRANSMITTING FILTER, LAMINATE, SOLID-STATE IMAGING ELEMENT, SENSOR, AND PATTERN FORMING METHOD | 2021-06-03 |
| 20210163635 | POLYMER COMPOSITION COMPRISING A POLYETHYLENE | 2021-06-03 |
| 20210163636 | CROSSLINKABLE COMPOSITION WITHOUT ANTIOXIDANT AND BENEFICIAL METHANE FORMATION WITH REDUCED CROSSLINKING | 2021-06-03 |
| 20210163637 | CABLE MADE FROM CROSSLINKABLE COMPOSITION WITHOUT ANTIOXIDANT AND WITH BENEFICIAL METHANE FORMATION | 2021-06-03 |
| 20210163638 | A POLYETHYLENE WITH A HIGH VINYL CONTENT AND WITH A LOW MFR | 2021-06-03 |
| 20210163639 | CATALYST SYSTEMS AND PROCESSES FOR USING THE SAME | 2021-06-03 |
| 20210163640 | Polyethylene and Chlorinated Polyethylene Thereof | 2021-06-03 |
| 20210163641 | CABLE JACKET | 2021-06-03 |
| 20210163642 | Ethylene Polymer Mixture, Method of Preparing the Same, and Molded Article Using the Same | 2021-06-03 |
| 20210163643 | Ethylene/Alpha-Olefin Copolymer and Method for Preparing the Same | 2021-06-03 |
| 20210163644 | A POLYETHYLENE WITH A HIGH VINYL CONTENT AND BENEFICIAL RHEOLOGICAL PROPERTIES | 2021-06-03 |
| 20210163645 | BINDER COMPOSITIONS AND METHODS OF PREPARING AND USING THE SAME | 2021-06-03 |
| 20210163646 | FOAMABLE RESIN PARTICLES AND METHOD OF PRODUCING SAME, AND FOAMED MOLDED BODY | 2021-06-03 |
| 20210163647 | FUNCTIONAL FLUOROPOLYMERS | 2021-06-03 |
| 20210163648 | FLUORINE-CONTAINING COPOLYMER AND METHOD FOR PRODUCING SAME | 2021-06-03 |
| 20210163649 | SINGLE-ION CONDUCTIVE POLYMERS FOR ELECTROCHEMICAL DEVICES | 2021-06-03 |
| 20210163650 | POLYMER MATERIAL | 2021-06-03 |
| 20210163651 | WATER-BASED RESIN COMPOSITION, WATER-BASED PAINT, AND ARTICLE | 2021-06-03 |
| 20210163652 | METHOD OF PREPARING GRAFT COPOLYMER | 2021-06-03 |
| 20210163653 | PROCESS FOR THE PRODUCTION OF GRAFT COPOLYMER POWDER COMPOSITIONS AND THERMOPLASTIC RESIN COMPOSITIONS | 2021-06-03 |
| 20210163654 | POLYVINYL ALCOHOL COMPOSITION, USE OF SAME, AND METHOD FOR PRODUCING VINYL RESIN | 2021-06-03 |
| 20210163655 | MEMBRANES FOR LIQUID TREATMENT | 2021-06-03 |
| 20210163656 | METHOD FOR MANUFACTURING GRAFT POLYMER, GRAFT POLYMER, AND INITIATOR OF GRAFT POLYMER | 2021-06-03 |
| 20210163657 | ZWITTERIONIC POLYMERS FOR BIOMEDICAL APPLICATIONS | 2021-06-03 |
| 20210163658 | BULK MATERIAL COMPRISING SOLID DIISOCYANATES AND PREPOLYMERS CONTAINING URETHANE GROUPS OBTAINABLE THEREFROM | 2021-06-03 |
| 20210163659 | STORAGE-STABLE POLYURETHANE CASTING COMPOUND FOR EMBEDDING HOLLOW FIBRES IN THE PRODUCTION OF FILTER ELEMENTS | 2021-06-03 |
| 20210163660 | TRANSPARENT HARD THERMOPLASTIC POLYURETHANES | 2021-06-03 |
| 20210163661 | METHOD FOR PRODUCING POLYURETHANE HARD FOAM COMPOSITE ELEMENTS USING MANNICH POLYOLS | 2021-06-03 |
| 20210163662 | PROCESS FOR PRODUCING POLYURETHANE/POLYISOCYANURATE (PUR/PIR) RIGID FOAMS | 2021-06-03 |
| 20210163663 | PROCESS FOR PRODUCING POLYURETHANE/POLYISOCYANURATE (PUR/PIR) RIGID FOAMS | 2021-06-03 |
| 20210163664 | ORTHODONTIC ARTICLES PREPARED USING A POLYCARBONATE DIOL, AND METHODS OF MAKING SAME | 2021-06-03 |
| 20210163665 | ONE COMPONENT THERMOSETTING EPOXY RESIN COMPOSITIONS | 2021-06-03 |
| 20210163666 | POLYOL COMPOSITION AND POLYURETHANE FOAM | 2021-06-03 |
| 20210163667 | CURABLE COMPOSITION COMPRISING AN ACETAL PLASTICIZER | 2021-06-03 |
| 20210163668 | ELECTROACTIVE POLYMERS | 2021-06-03 |
| 20210163669 | ISOCYANATE COMPOSITION WITH IMPROVED STABILITY AND REACTIVITY, AND OPTICAL LENS USING SAME | 2021-06-03 |
| 20210163670 | METHODS FOR REDUCING ALDEHYDE EMISSIONS IN POLYURETHANE FOAMS | 2021-06-03 |
| 20210163671 | METHOD FOR PREPARING COMPOUNDS WITH AN ALKOXYSILYL GROUP | 2021-06-03 |
